SIMPONI" (Golimumab) Receives Positive Opinion from Chmp for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis
Links shared publicly online about this topic.
- 1,941total visits
SIMPONI" (Golimumab) Receives Positive Opinion from Chmp for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis
jnj.com —
Johnson & Johnson news and information regarding our operations, products, leaders, and our charitable giving.
View full resource at jnj.com
Tags: Rheumatoid Arthritis, Rheumatoid Arthritis Medication, Spondyloarthropathy, Ankylosing Spondylitis, Psoriatic Arthritis, Simponi, Johnson & Johnson, Surgery
Most Recently Shared on June 26, 2009 at 4:22 pm By:
J&Js SIMPONIâ„¢ (Gets Thumbs Up from Chmp for 1xMonth Subcut Trtmnt of RA, Psoriatic Arthritis and Ankylosing Spondylitis http://bit.ly/5oiTM
Advertisement
